Fin Trust Capital Advisors, LLC Ionis Pharmaceuticals Inc Transaction History

Fin Trust Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $34,294 - $44,688	-732 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$59.06 - $72.15 $4,193 - $5,122	71 Added 10.74%	732 $44,000
Q2 2019 Aug 01, 2019	BUY	$62.09 - $86.14 $6,643 - $9,216	107 Added 19.31%	661 $42,000
Q4 2018 Feb 11, 2019	BUY	$43.37 - $59.54 $24,026 - $32,985	554 New	554 $30,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.